71 results on '"Abbou, Claude C."'
Search Results
2. The EAES Clinical Practice Guidelines on the Evaluation of Quality of Life After Laparoscopic Surgery (2004)
3. External Validation of Extranodal Extension and Lymph Node Density as Predictors of Survival in Node-positive Bladder Cancer after Radical Cystectomy
4. Impact of Body Mass Index on Perioperative Morbidity, Oncological, and Functional Outcomes After Extraperitoneal Laparoscopic Radical Prostatectomy
5. Transforming growth factor β-receptor II protein expression in benign prostatic hyperplasia is associated with prostate volume and inflammation
6. 509 IS BASELINE RENAL FUNCTION A DECISION-MAKING CRITERION FOR CHOOSING AN ABLATIVE TECHNIQUE RATHER THAN A PARTIAL NEPHRECTOMY IN SMALL RENAL MASSES?
7. Occupational exposure to polycyclic aromatic hydrocarbons influenced neither the frequency nor the spectrum of FGFR3 mutations in bladder urothelial carcinoma
8. THE USE OF NEPHRON SPARING SURGERY MAY FAVORABLY IMPACT THE RISK OF NON CANCER RELATED DEATH IN RENAL CELL CARCINOMA SURVIVORS
9. COMPARISON OF THE LEARNING CURVES FOR OPEN AND LAPAROSCOPIC RADICAL PROSTATECTOMY: AN INTERNATIONAL MULTICENTER STUDY
10. EARLY RENAL FUNCTION OUTCOMES FOLLOWING OPEN VS LAPAROSCOPIC PARTIAL NEPHRECTOMY: HOW DO THEY COMPARE?
11. ARE PIN AND ASAP DIAGNOSED ON EXTENDED PROSTATE BIOPSY ASSOCIATED WITH THE SAME RISK OF PROSTATE CANCER ON REBIOPSIES?
12. USING ADJUVANT CHEMO-HORMONO-THERAPY AFTER RADICAL PROSTATECTOMUY FOR LOCALLY ADVANCED PROSTATE CANCER PATIENTS DOES NOT DELAY CONTINENCE RECOVERY AND HAS A LOW IMPACT ON QUALITY OF LIFE: RESULTS OF MORBIDITY EVALUATION IN PRO 05 PHASE II RANDOMIZED TRIAL
13. INFLUENCE OF POSITIVE SURGICAL MARGINS ON ADJUVANT TREATMENT AFTER RADICAL PROSTATECTOMY
14. NEPHRON SPARING SURGERY (NSS) IS SUPERIOR TO RADICAL NEPHRECTOMY IN PRESERVING RENAL FUNCTION OUTCOME IN TUMORS LARGER THAN 4 CM
15. EXTRAPERITONEAL LAPAROSCOPIC RADICAL PROSTATECTOMY: THREE AND FIVE YEARS ONCOLOGIC RESULTS REGARDING 1115 CASES
16. COMPARISON OF OPEN VERSUS LAPAROSCOPIC PARTIAL NEPHRECTOMY: AVOIDING SELECTION BIAS BY MATCHED ANALYSIS
17. VEGF EXPRESSION AS BIOMARKER OF SUNITINIB CLINICAL RESPONSE IN METASTATIC RENAL CLEAR CELL CARCINOMA
18. External Validation of the Updated Partin Tables in a Cohort of French and Italian Men
19. BPH Gene Expression Profile Associated to Prostate Gland Volume
20. Prognostic variables to predict cancer-related death in incidental renal tumours
21. Erratum: Corrigendum: Regional copy number–independent deregulation of transcription in cancer
22. Collecting Duct Renal Cell Carcinoma: A Matched Analysis of 41 Cases
23. Use of Haemostatic Agents and Glues during Laparoscopic Partial Nephrectomy: A Multi-Institutional Survey from the United States and Europe of 1347 Cases
24. Morbidity and Clinical Outcome of Nephron-Sparing Surgery in Relation to Tumour Size and Indication
25. ECOG performance status 0 or 1 and symptom classification do not improve the ability to predict renal cell carcinoma-specific survival
26. Comparaison de la néphrectomie partielle par voie laparoscopique et par voie ouverte : une expérience multicentrique française
27. Regional copy number–independent deregulation of transcription in cancer
28. Characterization of ZAG protein expression in prostate cancer using a semi-automated microscope system
29. Protocadherin-PC promotes androgen-independent prostate cancer cell growth
30. Gefitinib Inhibits the Growth and Invasion of Urothelial Carcinoma Cell Lines in which Akt and MAPK Activation Is Dependent on Constitutive Epidermal Growth Factor Receptor Activation
31. Proposal for revision of the TNM classification system for renal cell carcinoma
32. Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy
33. Prognostic Value of Histologic Subtypes in Renal Cell Carcinoma: A Multicenter Experience
34. Multiinstitutional European validation of the 2002 TNM staging system in conventional and papillary localized renal cell carcinoma
35. SYMPTOMS AS WELL AS TUMOR SIZE PROVIDE PROGNOSTIC INFORMATION ON PATIENTS WITH LOCALIZED RENAL TUMORS
36. Use of the University of California Los Angeles Integrated Staging System to Predict Survival in Renal Cell Carcinoma: An International Multicenter Study
37. Open versus laparoscopic radical prostatectomy: Part II
38. Open versus laparoscopic radical prostatectomy: Part I
39. SAFETY AND EFFICACY OF PARTIAL NEPHRECTOMY FOR ALL T1 TUMORS BASED ON AN INTERNATIONAL MULTICENTER EXPERIENCE
40. Growth, Differentiation and Senescence of Normal Human Urothelium in an Organ-Like Culture
41. Pretreatment p53 Nuclear Overexpression as a Prognostic Marker in Superficial Bladder Cancer Treated with Bacillus Calmette–Guérin (BCG)
42. Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications
43. Urinary IL‐2 assay for monitoring intravesical bacillus Calmette‐Guérin response of superficial bladder cancer during induction course and maintenance therapy
44. FGFR3 and TP53 gene mutations define distinct pathways at initial diagnosis in urothelial cell carcinomas of the bladder
45. Epidermal Growth Factor Receptor Regulates Normal Urothelial Regeneration
46. Seminal vesicle involvement after radical prostatectomy: predicting risk factors for progression
47. Laparoscopic Radical Nephroureterectomy: Results of an International Multicenter Study
48. PROGNOSTIC VALUE OF A T HELPER 1 URINARY CYTOKINE RESPONSE AFTER INTRAVESICAL BACILLUS CALMETTE-GUERIN TREATMENT FOR SUPERFICIAL BLADDER CANCER
49. PROGNOSTIC VALUE OF A T HELPER 1 URINARY CYTOKINE RESPONSE AFTER INTRAVESICAL BACILLUS CALMETTE-GUERIN TREATMENT FOR SUPERFICIAL BLADDER CANCER
50. T HELPER 1/2 LYMPHOCYTE URINARY CYTOKINE PROFILES IN RESPONDING AND NONRESPONDING PATIENTS AFTER 1 AND 2 COURSES OF BACILLUS CALMETTE-GUERIN FOR SUPERFICIAL BLADDER CANCER
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.